Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of two nitroimidazoles and a dihydroquinoline as radiosensitizers and cytotoxic agents

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:5512155
The search for electron affinic compounds that exhibit the properties needed for a clinically useful hypoxic cell radiosensitizer has led to the setting up of clinical trials with misonidazole, which is a 2-nitroimidazole. Recently, MTDQ a new drug of novel design, a dihydroquinoline (6,6-methylene-bis-2,2,4-trimethyl-1,2-dihydroquinoline) has been synthesized and suggested as a radiosensitizer. The radiosensitizing and cytotoxic properties of misonidazole are compared with MTDQ and a second 2-nitroimadazole Ro-07-0741, which has warranted attention as a possible alternative to misonidazole for clinical use.
DOE Contract Number:
EP-78-S-02-4733
OSTI ID:
5512155
Conference Information:
Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Journal Volume: 5:10
Country of Publication:
United States
Language:
English

Similar Records

Ro-07-0582 as a radiosensitizer and cytotoxic agent. [Nitroimidazoles, nitrofurans]
Journal Article · Fri Dec 31 23:00:00 EST 1976 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5334042

Enhanced cytotoxicity of melphalan by prolonged exposure to nitroimidazoles: the role of endogenous thiols
Journal Article · Thu Dec 31 23:00:00 EST 1981 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:6864714

Radiosensitizing and toxic effects of the 2-nitroimidazole Ro-07-0582 in hypoxic mammalian cells. [Gamma radiation]
Journal Article · Wed Sep 01 00:00:00 EDT 1976 · Radiat. Res.; (United States) · OSTI ID:7333896